Term ended Nov 4, 2025 · High confidence
20-year base term ended Nov 4, 2025
Held by Mcure Biosciences Inc.
Filed Feb 19, 2013 as application 13/770,619 · Granted Oct 4, 2016
Base term, 20 years from filing
Today
Term ended Nov 4, 2025
2005
2026
Clock starts
Nov 4, 2005
Nov 4, 2005
Term ended
Nov 4, 2025
Nov 4, 2025
Granted
Oct 4, 2016
Oct 4, 2016
base term
after the term ends
fee events
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,377,435, to Nov 4, 2025. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 4, 2005, when application 11/267,935, the earliest non-provisional in its chain, was filed (this one was filed Feb 19, 2013) | Nov 4, 2025 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,377,435) | resolves to Nov 4, 2025, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Nov 4, 2025 | High confidence |
This family
| US 8,377,435 | In force Nov 2027 | Nov 2027 |
| US 9,458,241 | this patent Nov 2025 | Nov 2025 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 22, 2016 Reel 37877, frame 58 | Palingen, Inc. | Igm Biosciences, Inc. | Change of Name |
| Feb 6, 2018 Reel 44841, frame 203 | Igm Biosciences, Inc. | Igm Bisosciences A/S | Assignment of Assignor's Interest |
| Feb 6, 2018 Reel 44846, frame 591 | Igm Biosciences A/S | Igm Bisosciences, Inc. | Security Interest |
| Feb 22, 2018 Reel 45415, frame 838 | Igm Biosciences A/S | Igm Biosciences, Inc. | Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 044846 Frame: 0591. Assignor(S) Hereby Confirms the Security Interest. |
| Feb 22, 2018 Reel 45415, frame 858 | Igm Biosciences, Inc. | Igm Biosciences A/S | Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 044841 Frame: 0203. Assignor(S) Hereby Confirms the Assignment . |
| Sep 10, 2018 Reel 47044, frame 938 | Igm Biosciences A/S | Igm Biosciences, Inc. | Assignment of Assignor's Interest |
| Dec 3, 2018 Reel 47663, frame 525 | Igm Biosciences, Inc. | Igm Biosciences A/S | Release of Security Interest |
| Jan 8, 2020 Reel 51447, frame 373 | Bhat, Neelima M; Bieber, Marcia M | The Board of Trustees of the Leland Stanford Junior University | Assignment of Assignor's Interest |
| Jul 30, 2020 Reel 53352, frame 400 | Sanders, Martin E. | Paligen, Inc. | Assignment of Assignor's Interest |
| Jan 18, 2022 Reel 58767, frame 477 | Igm Biosciences, Inc. | Mcure Biosciences Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,377,435, ends no earlier than this term, so it caps nothing.
Citations
27
later US patents cite this one
That is top 25% of utility patents granted in 2016 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.